retatrutide safety profile More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide (LY-3437943) Market Analysis, 2033:

Adaptogenic herbs, such as Ashwagandha, may stimulate thyroid hormone synthesis, raising the possibility of overtreatment when combined with replacement therapy (250, 251)

Zeisberg, M., & Neilson, E

As with any supplement, consistency and moderation are key, and if you experience dizziness, extreme fatigue, or unusual reactions, discontinue use and seek medical guidance

Always tell your doctor about all the medicines you are taking

Adv Virus Res 60:421467

This hormone plays a crucial role in: GLP-1 receptor agonists, like semaglutide (the active ingredient in Ozempic and Wegovy), mimic this hormone to amplify its effects